财新传媒
财新英文 > 要闻 > 正文

In Depth: Chinese Drugmakers Find Fertile, but Challenging Market in Indonesia

By Zhou Xinda, Zhao Jinzhao and Guo Xin
2025年01月17日 18:52
Pharmaceutical firms are running into obstacles that include local protectionism and conflicting work cultures as they take their products to market in Southeast Asia’s largest economy
The Indonesian-owned Etana factory, in the east of Jakarta, works with more than 10 Chinese companies such as CanSino, Sinovac, Watson, Aibo, and Cinda. Photo: Zhou Xinda

Indonesia, Southeast Asia’s largest economy, is turning into a critical entry point for Chinese drugmakers looking to expand overseas.

However, the archipelago nation has presented them with challenges, along with the opportunities.

  [财新双语通产品,是为有双语需求读者专门订制的优惠产品, 按此可享超值优惠订阅。]

版面编辑:喻竹杨洋
财新网主编精选版电邮 样例
财新网新闻版电邮全新升级!财新网主编精心编写,每个工作日定时投递,篇篇重磅,可信可引。
订阅